Global DNA Ligase Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global DNA Ligase Market Research Report 2024
DNA ligase offers a connection between two strands of DNA by creating a bond between the deoxyribose group of one strand and the phosphate group on another. DNA ligase is an enzyme whereas during DNA replication there is the formation of lagging strand on which Okazaki fragments are presents separately and DNA ligase utilize to gather that fragments.
According to MRAResearch’s new survey, global DNA Ligase market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole DNA Ligase market research.
Key companies engaged in the DNA Ligase industry include Thermo Fisher Scientific, Hoffmann-La Roche, Agilent Technologies, Promega Corporation, New England Biolabs, Merck & Co., Amano Enzyme, BASF SE and Novozymes A/S, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of DNA Ligase were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole DNA Ligase market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global DNA Ligase market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Thermo Fisher Scientific
Hoffmann-La Roche
Agilent Technologies
Promega Corporation
New England Biolabs
Merck & Co.
Amano Enzyme
BASF SE
Novozymes A/S
Codexis
Segment by Type
Bacterias
Viruses
Animals
Plants
Others
Cloning
Mutation Detection
Next Generation Sequencing
Drug Target
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The DNA Ligase report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global DNA Ligase market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole DNA Ligase market research.
Key companies engaged in the DNA Ligase industry include Thermo Fisher Scientific, Hoffmann-La Roche, Agilent Technologies, Promega Corporation, New England Biolabs, Merck & Co., Amano Enzyme, BASF SE and Novozymes A/S, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of DNA Ligase were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole DNA Ligase market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global DNA Ligase market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Thermo Fisher Scientific
Hoffmann-La Roche
Agilent Technologies
Promega Corporation
New England Biolabs
Merck & Co.
Amano Enzyme
BASF SE
Novozymes A/S
Codexis
Segment by Type
Bacterias
Viruses
Animals
Plants
Others
Segment by Application
Cloning
Mutation Detection
Next Generation Sequencing
Drug Target
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The DNA Ligase report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source